As of the latest SEC filings, Wave Life Sciences, Inc. (WVE) is held by 209 institutional funds. The largest fund shareholder is PRIMECAP Odyssey Aggressive Growth Fund (POAGX), holding an estimated $27,342,836.38 in market value, representing 0.40% of its portfolio.
Funds holding Wave Life Sciences, Inc. (WVE)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- WVE
- CIK:
- 0001631574
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
POAGX
PRIMECAP Odyssey Aggressive Growth Fund
|
MF | Independent / Boutique | 0.40% | $27,342,836.38 | 3,872,923 | Apr 30, 2026 | Jun 29, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.03% | $24,687,555.00 | 3,405,180 | Mar 31, 2026 | May 28, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.03% | $23,150,392.37 | 1,661,909 | Feb 28, 2026 | Apr 24, 2026 |
|
FSPHX
Select Health Care Portfolio
|
MF | Fidelity | 0.36% | $22,288,000.00 | 1,600,000 | Feb 28, 2026 | Apr 24, 2026 |
|
PRJIX
T. Rowe Price New Horizons Fund, Inc.
|
MF | T. Rowe Price | 0.13% | $16,581,496.75 | 2,287,103 | Mar 31, 2026 | May 28, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.14% | $15,277,439.25 | 2,107,233 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $11,679,467.25 | 1,610,961 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.03% | $10,534,353.55 | 756,235 | Feb 28, 2026 | Apr 24, 2026 |
|
FCTDX
Strategic Advisers Fidelity U.S. Total Stock Fund
|
MF | Fidelity | 0.00% | $10,308,200.00 | 740,000 | Feb 28, 2026 | Apr 24, 2026 |
|
PRDSX
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund
|
MF | T. Rowe Price | 0.12% | $10,240,581.50 | 1,412,494 | Mar 31, 2026 | May 28, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.05% | $9,818,490.85 | 704,845 | Feb 28, 2026 | Apr 24, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.03% | $9,762,553.88 | 1,382,798 | Apr 30, 2026 | Jun 26, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.10% | $8,527,348.50 | 1,176,186 | Mar 31, 2026 | May 28, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.05% | $7,988,659.98 | 573,486 | Feb 28, 2026 | Apr 28, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.06% | $7,328,561.00 | 1,010,836 | Mar 31, 2026 | May 28, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.13% | $6,785,860.20 | 487,140 | Feb 28, 2026 | Apr 24, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.03% | $6,635,179.39 | 476,323 | Feb 28, 2026 | Apr 24, 2026 |
|
QASCX
Federated Hermes MDT Small Cap Core Fund
|
MF | Federated Hermes | 0.28% | $5,272,746.88 | 746,848 | Apr 30, 2026 | Jun 23, 2026 |
|
DNSMX
Driehaus Small Cap Growth Fund
|
MF | Independent / Boutique | 0.43% | $4,961,240.25 | 684,309 | Mar 31, 2026 | May 27, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.07% | $4,818,136.26 | 345,882 | Feb 27, 2026 | Apr 24, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.02% | $4,655,364.21 | 334,197 | Feb 28, 2026 | Apr 28, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.02% | $4,156,712.00 | 298,400 | Feb 28, 2026 | Apr 24, 2026 |
|
FPHAX
Select Pharmaceuticals Portfolio
|
MF | Fidelity | 0.27% | $4,134,424.00 | 296,800 | Feb 28, 2026 | Apr 24, 2026 |
|
LFSC
F/m Emerald Life Sciences Innovation ETF
|
ETF | Independent / Boutique | 4.21% | $4,024,836.69 | 288,933 | Feb 28, 2026 | Apr 28, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $3,733,267.86 | 268,002 | Feb 28, 2026 | Apr 24, 2026 |
Advertisement (320x50)